Venetoclax for the Treatment of Chronic Lymphocytic Leukemia. [electronic resource]
Producer: 20200730Description: 469-476 p. digitalISSN:- 1558-822X
- Antineoplastic Agents -- administration & dosage
- Biomarkers, Tumor
- Bridged Bicyclo Compounds, Heterocyclic -- administration & dosage
- Chromosome Aberrations
- Disease Progression
- Drug Resistance, Neoplasm
- Gene Expression Regulation, Leukemic
- Genetic Predisposition to Disease
- Humans
- Leukemia, Lymphocytic, Chronic, B-Cell -- diagnosis
- Molecular Targeted Therapy
- Proto-Oncogene Proteins c-bcl-2 -- genetics
- Recurrence
- Sulfonamides -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.